Berberine attenuates TNBS-induced colitis in mice by improving the intestinal microbiota
BBR has a therapeutic effect on TNBS-induced colitis in mice, which is associated with modifications in immune cell subpopulations and intestinal microecology. It also offers a viable approach as a prospective probiotic (like <i>Akkermansia muciniphila</i>) to IBD therapy in clinical settings.
Authors
- Changpeng Xie
- Yuanming Pan (ORCID: https://orcid.org/0000-0001-8050-8047)
- Juan An (ORCID: https://orcid.org/0000-0002-6356-3447)
- Jin Zeng (ORCID: https://orcid.org/0000-0002-0872-587X)
- Panjian Wei (ORCID: https://orcid.org/0000-0001-9678-4361)
- Siai Chen (ORCID: https://orcid.org/0009-0003-5018-9155)
- Meng Gu (ORCID: https://orcid.org/0000-0002-2394-4245)
- Wěi Li (ORCID: https://orcid.org/0000-0002-9522-4474)
- Chao Li (ORCID: https://orcid.org/0000-0003-3863-0289)
- Ziyu Wang (ORCID: https://orcid.org/0009-0009-3465-0806)
- Xinxin Yin (ORCID: https://orcid.org/0000-0002-2886-5319)
- Guibin Yang (ORCID: https://orcid.org/0009-0004-8461-7514)
- Chuan Song
- Jinglei Zhang (ORCID: https://orcid.org/0009-0009-4160-9828)
Institutions
- Qinghai University (CN)
- Capital Medical University (CN)
- Peking University (CN)
- Beijing Chest Hospital (CN)
- Aerospace Center Hospital (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fmicb.2024.1463005
- Citations
- 8
- Primary Topic
- Berberine and alkaloids research
- Type
- article
- Field-Weighted Citation Impact
- 3.58
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation